---
schema_version: "secwatch.filing_event.v1"
accession: "0001035267-22-000165"
form_type: "8-K"
ticker: "ISRG"
cik: "0001035267"
company_name: "INTUITIVE SURGICAL INC"
filed_at: "2022-10-18T23:59:59+00:00"
generated_at: "2026-06-23T02:51:24.569856+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.85
calibrated_materiality_score: 0.85
confidence: "high"
source: SEC EDGAR
---

# Intuitive Q3 revenue $1.56B up 11% YoY; GAAP EPS $0.90 vs $1.04

## Summary
- Worldwide da Vinci procedures grew ~20% YoY; installed base 7,364 systems (+13%).
- System placements of 305, down 9% from 336 in Q3 2021.
- Non-GAAP EPS $1.19 flat YoY; GAAP net income $324M vs $381M.
- Repurchased $1B of common stock in Q3 2022.
- Japan cleared da Vinci SP for several surgical indications in September 2022.

## SEC filing metadata
- accession: 0001035267-22-000165
- form_type: 8-K
- ticker: ISRG
- cik: 0001035267
- company_name: INTUITIVE SURGICAL INC
- filed_at: 2022-10-18T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.85
- calibrated_materiality_score: 0.85
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1035267/000103526722000165/0001035267-22-000165-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1035267/000103526722000165/isrg-20221018.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001035267-22-000165
- JSON: https://secwatch.observer/filing/0001035267-22-000165.json
- Plain text: https://secwatch.observer/filing/0001035267-22-000165.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.